Adherence With Iron Sprinkles Among High-Risk Infants
Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron deficiency.
Drug: Ferrous sulphate drops with vitamins A, D, and C
Drug: Ferrous fumarate sprinkles with vitamins and minerals
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||Adherence With Iron Sprinkles Among High-Risk Infants|
- full adherence, use of iron supplements 6-7 days/week for 3 months
- iron deficiency at 9 months of age
- anemia at 9 months of age
|Study Start Date:||March 2005|
|Study Completion Date:||December 2005|
Iron deficiency is the most common known nutrient deficiency and cause of anemia in childhood. It is associated with numerous adverse health effects, particularly delayed mental and motor development, that may be irreversible. Despite advances of iron nutrition, the prevalence of iron deficiency remains high among low-income infants and toddlers. Previous studies suggest adherence with iron containing drops is low. Adherence to iron sprinkles among children as tested in studies in less developed countries appears high.
Comparison: Children randomized to ferrous sulfate drops will be compared with children randomized to ferrous fumarate sprinkles.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00136266
|United States, Massachusetts|
|Boston Medical Center Pediatric Primary Care Clinic|
|Boston, Massachusetts, United States, 02118|
|Whittier Street Health Center|
|Boston, Massachusetts, United States, 02108|
|Principal Investigator:||Paul L. Geltman, MD, MPH||Boston University|